Escaping Antiangiogenic Therapy: Strategies Employed by Cancer Cells

by Mauricio P. Pinto, Paula Sotomayor, Gonzalo Carrasco-Avino, Alejandro H. Corvalan, Gareth I. Owen
Published 2016-09-01

Class I histone deacetylase inhibitor entinostat suppresses regulatory T cells and enhances immunotherapies in renal and prostate cancer models.

by Li Shen, Michael Ciesielski, Swathi Ramakrishnan, Kiersten M Miles, Leigh Ellis, Paula Sotomayor, Protul Shrikant, Robert Fenstermaker, Roberto Pili
Published 2012-01-01

Dll4 blockade potentiates the anti-tumor effects of VEGF inhibition in renal cell carcinoma patient-derived xenografts.

by Kiersten Marie Miles, Mukund Seshadri, Eric Ciamporcero, Remi Adelaiye, Bryan Gillard, Paula Sotomayor, Kristopher Attwood, Li Shen, Dylan Conroy, Frank Kuhnert, Alshad S Lalani, Gavin Thurston, Roberto Pili
Published 2014-01-01